Published in
American Medical Association, JAMA Cardiology, 7(4), p. 613, 2019
DOI: 10.1001/jamacardio.2019.0886
Links
Tools
Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular Disease
Journal article published in 2019 by
Sabina A. Murphy,
Terje R. Pedersen,
Zbigniew A. Gaciong,
Richard Ceska,
Marat V. Ezhov,
Derek L. Connolly 
,
J. Wouter Jukema,
Kalman Toth,
Matti J. Tikkanen,
Kyungah Im,
Stephen D. Wiviott,
Christopher E. Kurtz,
Narimon Honarpour,
Robert P. Giugliano,
Anthony C. Keech
and other authors.
,
J. Wouter Jukema,
Kalman Toth,
Matti J. Tikkanen,
Kyungah Im,
Stephen D. Wiviott,
Christopher E. Kurtz,
Narimon Honarpour,
Robert P. Giugliano,
Anthony C. Keech
and other authors.
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 